Keratan sulfate expression in microglia is diminished in the spinal cord in experimental autoimmune neuritis

Cell Death and Disease

Volumn 4, Issue 12, 2013, Pages

  Matsui, H ^a   Ohgomori, T ^a   Natori, T ^b   Miyamoto, K ^c   Kusunoki, S ^c   Sakamoto, K ^a   Ishiguro, N ^a   Imagama, S ^a   Kadomatsu, K ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMANASHI GAKUIN UNIVERSITY   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

experimental autoimmune neuritis; keratan sulfate; microglia

Indexed keywords

CHLORDANE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; KERATAN SULFATE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; EXPERIMENTAL AUTOIMMUNE NEURITIS; MACROPHAGE; MICROGLIA; NERVOUS SYSTEM INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; SPINAL CORD DORSAL HORN; SPINAL CORD VENTRAL HORN; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; KERATAN SULFATE; MALE; MICROGLIA; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; RATS; REAL-TIME POLYMERASE CHAIN REACTION; SPINAL CORD;

EID: 84891822851     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.479     Document Type: Article

References (34)

1. Zhang Z, Zhang ZY, Schluesener HJ. Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects. J Immunol 2009; 183: 3081-3091
2. Hughes RAC. Systematic reviews of treatment for inflammatory demyelinating neuropathy. J Anat 2002; 200: 331-339
3. Kieseier BC, Kiefer R, Gold R, Hemmer B, Willison HJ, Hartung HP. Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 2004; 30: 131-156
4. Hahn AF. Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies. Rev Neurol 1996; 152: 328-332
5. Hughes RA, Cornblath DR. Guillain-Barre syndrome. Lancet 2005; 366: 1653-1666
6. Winer JB. Guillain Barre syndrome. Mol Pathol 2001; 54: 381-385
7. Beiter T, Artelt MR, Trautmann K, Schluesener HJ. Experimental autoimmune neuritis induces differential microglia activation in the rat spinal cord. J Neuroimmunol 2005; 160: 25-31
8. Zhang Z, Zhang ZY, Fauser U, Schluesener HJ. Mechanical allodynia and spinal upregulation of P2X4 receptor in experimental autoimmune neuritis rats. Neuroscience 2008; 152: 495-501
9. Brunn A, Utermöhlen O, Carstov M, Ruiz MS, Miletic H, Schlü ter D et al. CD4 T cells mediate axonal damage and spinal cord motor neuron apoptosis in murine p0106-125-induced experimental autoimmune neuritis. Am J Pathol 2008; 173: 93-105
10. Johnson-Green PC, Dow KE, Riopelle RJ. Characterization of glycosaminoglycans produced by primary astrocytes in vitro. Glia 1991; 4: 314-321
11. Scott JE, Cummings C, Greiling H, Stuhlsatz HW, Gregory JD, Damle SP. Examination of corneal proteoglycans and glycosaminoglycans by rotary shadowing and electron microscopy. Int J Biol Macromol 1990; 12: 180-184
12. Uchimura K, El-Fasakhany FM, Hori M, Hemmerich S, Blink SE, Kansas GS et al. Specificities of N-Acetylglucosamine-6-O-sulfotransferases in relation to L-selectin ligand synthesis and tumor-Associated enzyme expression. J Biol Chem 2002; 277: 3979-3984
13. Zhang H, Muramatsu T, Murase A, Yuasa S, Uchimura K, Kadomatsu K. N-Acetylglucosamine 6-O-sulfotransferase-1 is required for brain keratan sulfate biosynthesis and glial scar formation after brain injury. Glycobiology 2006; 16: 702-710
14. Jones LL, Tuszynski MH. Spinal cord injury elicits expression of keratan sulfate proteoglycans by macrophages, reactive microglia, and oligodendrocyte progenitors. J Neurosci 2002; 22: 4611-4624
15. Ito Z, Sakamoto K, Imagama S, Matsuyama Y, Zhang H, Hirano K et al. N-Acetylglucosamine 6-O-sulfotransferase-1-deficient mice show better functional recovery after spinal cord injury. J Neurosci 2010; 30: 5937-5947
16. Imagama S, Sakamoto K, Tauchi R, Shinjo R, Ohgomori T, Ito Z et al. Keratan sulfate restricts neural plasticity after spinal cord injury. J Neurosci 2011; 31: 17091-17102
17. Graeber MB. Changing face of microglia. Science 2010; 330: 783-788
18. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009; 29: 13435-13444
19. Mikita J, Dubourdieu-Cassagno N, Deloire MS, Vekris A, Biran M, Raffard G et al. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult Scler 2011; 17: 2-15
20. Lu MO, Zhu J. The role of cytokines in Guillain-Barre syndrome. J Neurol 2011; 258: 533-548
21. Jander S, Schroeter M, Fischer J, Stoll G. Differential regulation of microglial keratan sulfate immunoreactivity by proinflammatory cytokines and colony-stimulating factors. Glia 2000; 30: 401-410
22. Kobayashi K, Imagama S, Ohgomori T, Hirano K, Uchimura K, Sakamoto K et al. Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis 2013; 4: E525
23. Hirano K, Ohgomori T, Kobayashi K, Tanaka F, Matsumoto T, Natori T et al. Ablation of keratan sulfate accelerates early phase pathogenesis of ALS. PLoS One 2013; 8: E66969
24. Tauchi R, Imagama S, Natori T, Ohgomori T, Muramoto A, Shinjo R et al. The endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes functional recovery after spinal cord injury. J Neuroinflammation 2012; 9: 53
25. Tauchi R, Imagama S, Ohgomori T, Natori T, Shinjo R, Ishiguro N et al. ADAMTS-13 is produced by glial cells and upregulated after spinal cord injury. Neurosci Lett 2012; 517: 1-6
26. Jander S, Stoll G. Downregulation of microglial keratan sulfate proteoglycans coincident with lymphomonocytic infiltration of the rat central nervous system. Am J Pathol 1996; 148: 71-78
27. Jander S, Stoll G. Strain-specific expression of microglial keratan sulfate proteoglycans in the normal rat central nervous system: Inverse correlation with constitutive expression of major histocompatibility complex class II antigens. Glia 1996; 18: 255-260
28. Ponomarev ED, Veremeyko T, Barteneva N, Krichevsky AM, Weiner HL. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-A-PU.1 pathway. Nat Med 2011; 17: 64-70
29. Graff JW, Dickson AM, Clay G, McCaffrey AP, Wilson ME. Identifying functional microRNAs in macrophages with polarized phenotypes. J Biol Chem 2012; 287: 21816-21825
30. Miyamoto K, Oka N, Kawasaki T, Miyake S, Yamamura T, Akiguchi I. New cyclooxygenase-2 inhibitors for treatment of experimental autoimmune neuritis. Muscle Nerve 2002; 25: 280-282
31. Khorooshi R, Owens T. Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system. J Immunol 2010; 185: 1258-1264
32. Jin X, Ishii H, Bai Z, Itokazu T, Yamashita T. Temporal changes in cell marker expression and cellular infiltration in a controlled cortical impact model in adult male C57BL/6 mice. PLoS One 2012; 7: E41892
33. Chiu IM, Chen A, Zheng Y, Kosaras B, Tsiftsoglou SA et al. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc Natl Acad Sci USA 2008; 105: 17913-17918
34. Locatelli G, Wö rtge S, Buch T, Ingold B, Frommer F et al. Primary oligodendrocyte death does not elicit anti-CNS immunity. Nat Neurosci 2012; 15: 543-550 Technology